Drug industry embraces new business strategies after tough year
Thursday, December 10, 2009 - 03:21
in Mathematics & Economics
As they pop the champagne corks to celebrate New Year's Eve, drug industry executives will likely be glad to put 2009 behind them. That's because pharmaceutical companies who make top-selling drugs for heart disease, asthma, and many other conditions had a tough year in the midst of mounting market pressures and a global recession. A timely year-end analysis of the state of the pharmaceutical industry is scheduled for the current issue of Chemical and Engineering News, ACS' weekly newsmagazine...
Read the whole article on Science Centric
More from Science Centric
Related
- Drug industry embraces new business strategies after tough yearWed, 9 Dec 2009, 15:17:15 EST
- Drug industry, nonprofits join forces to fight world's neglected diseasesWed, 11 Nov 2009, 11:26:00 EST
- Fancier fakes: Makers of bogus prescription drugs pose new challengesWed, 6 Jan 2010, 12:33:18 EST
- Sponsoring by the pharmaceutical industry can bias the results of drug studiesFri, 7 May 2010, 10:47:01 EDT
- Quest for new plant protection substances mirrors search for new drugsWed, 20 Apr 2011, 11:06:33 EDT